Skip to main content
Equibles
NVAX logo

NVAX · Novavax Inc · Metrics

Track NVAX — free

Use NVAX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NVAX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.04 +0.04 (+0.40%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.58B
Shares
164.95M

NVAX metrics

62 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.00
Market cap
$1.58B

Price action

20 metrics
Price change (1W)
+7.5%
Price change (30D)
+13.8%
Price change (3M)
+9.5%
Price change (6M)
+2.7%
Price change (YTD)
+48.8%
Price change (1Y)
+19.2%
Trailing year
Price change (5Y)
-95.8%
52-week high
$11.19
52-week low
$6.22
Change from 52-week high
-10.6%
Change from 52-week low
+60.8%
Annualized volatility
64.8%
Annualized volatility (3M)
51.9%
Beta
1.9
RSI (14D)
60.8
Price vs SMA 50
+16.1%
Price vs SMA 200
+15.3%
Avg volume (3M)
4.40M
Relative volume
2.0
Average dollar volume
$39.29M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
164.95M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.8×
reciprocal yield 26.2%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-15.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
78.6%
Operating margin
-56.6%
Trailing 12 months
Net margin
-59.9%
Gross profit (TTM)
—
Operating profit (TTM)
−$234.12M
Net income (TTM)
−$247.73M
Trailing 12 months
Diluted EPS (TTM)
$-1.35
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.79

Growth

11 metrics
Revenue growth YoY
-76.3%
Year over year
Net income growth YoY
-150.1%
Revenue (TTM)
$413.80M
Trailing 12 months
EPS growth YoY
-151.6%
Shares change YoY
-7.1%
Year over year · fewer shares
Revenue CAGR (3Y)
-17.2%
Revenue CAGR (5Y)
+18.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-25.9%
Debt / equity
—
Current ratio
2.3
EBITDA (TTM)
−$215.91M
Free cash flow (TTM)
—
Quick ratio
2.3
Interest coverage
-10.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$191.46M
Total assets
$955.58M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$36.90M
Capital expenditures (TTM)
$82.40M
R&D (TTM)
$340.31M
SG&A (TTM)
$121.22M
Stock compensation (TTM)
$32.33M
R&D / revenue
82.2%
Stock compensation / revenue
7.8%

Ownership (13F)

3 metrics
13F filers
270
13F filer change QoQ
+7
Institutional ownership
77.7%

Short interest

3 metrics
Short interest
29.6%
Latest settlement · 8.6 days to cover
Days to cover
8.6d
Short-squeeze score
78 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1000694 CUSIP 670002401 13F (30d) 10 filings 9 filers Visit website Investor relations